Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Regen Biopharma (RGBP)
OTHER OTC:RGBP
Regen Biopharma (RGBP) Stock Price & Analysis
61 Followers
RGBP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.40 - $2.62
Previous Close$0.65
Volume4.40K
Average Volume (3M)16.73K
Market Cap
$2.33M
Enterprise Value$3.02M
Total Cash (Recent Filing)$124.50K
Total Debt (Recent Filing)$704.07K
Price to Earnings (P/E)-2.7
Beta0.77
Next Earnings
May 14, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding3,928,091
10 Day Avg. Volume18,646
30 Day Avg. Volume16,728
Standard Deviation0.94
R-Squared0.02
Alpha0.11
Financial Highlights & Ratios
Price to Book (P/B)-0.52
Price to Sales (P/S)20.34
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue19.60
Enterprise Value/Gross Profit365.04
Enterprise Value/Ebitda1.98
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Regen Biopharma News
PremiumCompany Announcements
Regen Biopharma Files Patent for Blood Recovery TreatmentOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
RGBP FAQ
What was Regen Biopharma’s price range in the past 12 months?
Regen Biopharma lowest stock price was $0.40 and its highest was $2.62 in the past 12 months.
What is Regen Biopharma’s market cap?
Currently, no data Available
When is Regen Biopharma’s upcoming earnings report date?
Regen Biopharma’s upcoming earnings report date is May 14, 2018 which is 2177 days ago.
How were Regen Biopharma’s earnings last quarter?
Currently, no data Available
Is Regen Biopharma overvalued?
According to Wall Street analysts Regen Biopharma’s price is currently Overvalued.
Does Regen Biopharma pay dividends?
Regen Biopharma does not currently pay dividends.
What is Regen Biopharma’s EPS estimate?
Regen Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regen Biopharma have?
Regen Biopharma has 3,750,565 shares outstanding.
What happened to Regen Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Regen Biopharma?
Currently, no hedge funds are holding shares in RGBP
---
Regen Biopharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.17%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-61.48%
Trailing 12-Months
Company Description
Regen Biopharma
Regen Biopharma, Inc. engages in the development of regenerative medical applications licensed from other companies. It focuses on the immunology and immonutherapy research for the areas of Hematopoiesis, Breast Cancer, Liver Cancer, Leukemia, Myelodysplastic Syndrome, and Aplastic Anemia. The company was founded on April 24, 2012 and is headquartered in La Mesa, CA.
---
Technical Analysis
---